Business Model:
Revenue: $0
Employees: 0-0
Jolly Pharmaceutical was acquired by
Huadong Medicine.
The acquisition happend on 2019-05-27.
Details of the transaction were not public
Address:
City:
State:
Zip:
Country:
Jolly Pharmaceutical engages in the research, production, and marketing of chinese medicinal products.
Contact Phone:
Contact Email:
Listed Exchange:
SZSE
IPO Date:
2/22/2011
Ticker Symbol:
300181
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2019 | Tongtongeyan | Venture Round | 7.1M |
9/2018 | Zhufeng Pharmaceutical | Secondary Market | 17.5M |
1/2022 | TOP MEDICINE | Post-IPO Equity | 1.7M |
1/2022 | TOP MEDICINE | Post-IPO Equity | 0 |
12/2019 | Tongtongeyan | Venture Round | 0 |
9/2018 | Zhufeng Pharmaceutical | Secondary Market | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|